Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KRT8 Antikörper (CF®640R)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch KRT8 in WB, IHC, IF und IHC (fp). Er zeigt eine Reaktivität gegenüber Human, Rind (Kuh), Kaninchen, Schwein und Schaf.
Produktnummer ABIN7656253

Kurzübersicht für KRT8 Antikörper (CF®640R) (ABIN7656253)

Target

Alle KRT8 Antikörper anzeigen
KRT8 (Keratin 8 (KRT8))

Reaktivität

  • 314
  • 89
  • 78
  • 66
  • 64
  • 62
  • 61
  • 16
  • 14
  • 10
  • 8
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Human, Rind (Kuh), Kaninchen, Schwein, Schaf

Wirt

  • 168
  • 163
  • 3
Maus

Klonalität

  • 184
  • 147
  • 1
Monoklonal

Konjugat

  • 173
  • 27
  • 17
  • 12
  • 9
  • 8
  • 8
  • 8
  • 8
  • 8
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser KRT8 Antikörper ist konjugiert mit CF®640R

Applikation

  • 239
  • 175
  • 123
  • 89
  • 71
  • 49
  • 47
  • 42
  • 41
  • 40
  • 37
  • 29
  • 22
  • 5
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))

Klon

B22-1
  • Verwendungszweck

    Cytokeratin 8 (KRT8)(B22.1), CF640R conjugate

    Produktmerkmale

    Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogen

    Cytoskeletal preparation from HeLa cells

    Isotyp

    IgG1, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    Positive Control: MCF-7 or A431 cells. Skin, Colon, lung or breast carcinoma

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.1 mg/mL

    Buffer

    PBS, 0.1 % BSA, 0.05 % azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Protect from light

    Lagerung

    4 °C

    Informationen zur Lagerung

    Stable at room temperature or 37°C for 7 days.

    Protect from light

    Store at 2 to 8°C. Protect fluorescent conjugates from light

    Haltbarkeit

    24 months
  • Target

    KRT8 (Keratin 8 (KRT8))

    Andere Bezeichnung

    Keratin 8

    Hintergrund

    Synonyms: CARD2, CK8, CYK8, CYKER, Cytokeratin Endo A, DreK8, EndoA, K2C8, K8, Keratin 8, Krt 2.8, KRT8, Type-II Keratin Kb8

    Gene Symbol: KRT8

    Tissue Expression: Epithelial cells

    Molekulargewicht

    52.5 kDa

    Gen-ID

    3856

    UniProt

    P05787
Sie sind hier:
Chat with us!